CA2511237A1 - Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles - Google Patents

Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles Download PDF

Info

Publication number
CA2511237A1
CA2511237A1 CA002511237A CA2511237A CA2511237A1 CA 2511237 A1 CA2511237 A1 CA 2511237A1 CA 002511237 A CA002511237 A CA 002511237A CA 2511237 A CA2511237 A CA 2511237A CA 2511237 A1 CA2511237 A1 CA 2511237A1
Authority
CA
Canada
Prior art keywords
infectious disease
data set
profile data
inflammatory conditions
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002511237A
Other languages
English (en)
French (fr)
Inventor
Michael C. Bevilacqua
Victor Tryon
Danute M. Bankaitis-Davis
John C. Cheronis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2511237A1 publication Critical patent/CA2511237A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002511237A 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles Abandoned CA2511237A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43525702P 2002-12-19 2002-12-19
US60/435,257 2002-12-19
PCT/US2003/040551 WO2004057034A1 (en) 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles

Publications (1)

Publication Number Publication Date
CA2511237A1 true CA2511237A1 (en) 2004-07-08

Family

ID=32682206

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002511237A Abandoned CA2511237A1 (en) 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles

Country Status (8)

Country Link
EP (1) EP1579008A1 (ja)
JP (2) JP2006510382A (ja)
CN (1) CN1751129B (ja)
AU (1) AU2003303238B2 (ja)
BR (1) BR0317612A (ja)
CA (1) CA2511237A1 (ja)
MX (1) MXPA05006804A (ja)
WO (1) WO2004057034A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668111A4 (en) 2003-08-08 2008-07-02 Genenews Inc OSTEOARTHRITIS BIOMARKERS AND USES THEREOF
EP1869463A4 (en) 2005-04-15 2010-05-05 Becton Dickinson Co SEPSIS DIAGNOSIS
WO2007038754A2 (en) * 2005-09-27 2007-04-05 Source Mdx Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
US20080227655A1 (en) * 2006-05-16 2008-09-18 Michael Bevilacqua Assessment of effect of an agent on a human biological condition using rodent gene expression panels
WO2008048986A2 (en) * 2006-10-17 2008-04-24 Children's Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
DE102007036678B4 (de) * 2007-08-03 2015-05-21 Sirs-Lab Gmbh Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion
WO2011123745A2 (en) * 2010-04-02 2011-10-06 Opko Curna Llc Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
BR112017019373A2 (pt) * 2015-03-12 2018-06-05 Koninklijke Philips N.V. método implementado por computador, e, mídia legível por computador
US11031119B2 (en) * 2019-11-13 2021-06-08 Cube Click, Inc. Dental images processed with deep learning for national security

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273847C (en) * 1996-12-06 2013-08-13 Urocor, Inc. Diagnosis of disease state using mrna profiles
PT1198585E (pt) * 1999-06-28 2007-09-20 Source Precision Medicine Inc Processo para caracterizar uma condição biológica usando perfis calibrados da expressão de genes
EP1451340B1 (en) * 2001-11-09 2014-01-08 Life Technologies Corporation Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

Also Published As

Publication number Publication date
MXPA05006804A (es) 2006-03-30
JP2010227111A (ja) 2010-10-14
WO2004057034A1 (en) 2004-07-08
CN1751129A (zh) 2006-03-22
BR0317612A (pt) 2005-12-06
EP1579008A1 (en) 2005-09-28
AU2003303238B2 (en) 2010-07-22
CN1751129B (zh) 2014-07-23
AU2003303238A1 (en) 2004-07-14
JP2006510382A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
US20180060481A1 (en) Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles
US8718946B2 (en) Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6960439B2 (en) Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US7935482B2 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
EP1198585B1 (en) Method for characterizing a biological condition using calibrated gene expression profiles
US20040219568A1 (en) Systems and methods for characterizing a biological conditions or agent using selected gene expression profiles
US20080233573A1 (en) Gene expression profiling for identification, monitoring and treatment of transplant rejection
JP2005508505A5 (ja)
US20040225449A1 (en) Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
AU2003303238B2 (en) Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles
US20060115826A1 (en) Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US20110300542A1 (en) Gene Expression Profiling For Identification, Monitoring And Treatment Of Multiple Sclerosis
AU2003303238A2 (en) Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles
AU2006259306B2 (en) Gene expression profiling for identification and monitoring of multiple sclerosis
US20110092390A1 (en) Assessment of effect of an agent on a human biological condition using rodent gene expression panels

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20120924